CoChat

Future directions in acute liver failure

Open access
Stravitz, R. Todd, Fontana, Robert J., Karvellas, Constantine, Durkalski, Valerie, McGuire, Brendan, Rule, Jody A., Tujios, Shannan, Lee, William M., for the Acute Liver Failure Study Group · 2023 · Hepatology
Cited by 132

The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.

Abstract

Acute liver failure (ALF) describes a clinical syndrome of rapid hepatocyte injury leading to liver failure manifested by coagulopathy and encephalopathy in the absence of pre-existing cirrhosis. The hallmark diagnostic features are a prolonged prothrombin time (ie, an international normalized ratio of prothrombin time of ≥1.5) and any degree of mental status alteration (HE). As a rare, orphan disease, it seemed an obvious target for a multicenter network. The Acute Liver Failure Study Group (ALFSG) began in 1997 to more thoroughly study and understand the causes, natural history, and management of ALF. Over the course of 22 years, 3364 adult patients were enrolled in the study registry (2614 ALF and 857 acute liver injury—international normalized ratio 2.0 but no encephalopathy—ALI) and >150,000 biosamples collected, including serum, plasma, urine, DNA, and liver tissue. Within the Registry study sites, 4 prospective substudies were conducted and published, 2 interventional (N-acetylcysteine and ornithine phenylacetate), 1 prognostic [13 C-methacetin breath test (MBT)], and 1 mechanistic (rotational thromboelastometry). To review ALFSG’s accomplishments and consider next steps, a 2-day in-person conference was held at UT Southwestern Medical Center, Dallas, TX, entitled “Acute Liver Failure: Science and Practice,” in May 2022. To summarize the important findings in the field, this review highlights the current state of understanding of ALF and, more importantly, asks what further studies are needed to improve our understanding of the pathogenesis, natural history, and management of this unique and dramatic condition.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/hep.0000000000000458

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 21 references

Research works printed but not linked: 143

  1. Trey, 1970, The management of fulminant hepatic failure, Prog Liver Dis, 3, 282
  2. Lee, 2008, Acute liver failure: summary of a workshop, Hepatology, 47, 1401, 10.1002/hep.22177 · DOI · Paper page
  3. Stravitz, 2019, Seminar: Acute liver failure, Lancet, 394, 869, 10.1016/S0140-6736(19)31894-X · DOI · Paper page
  4. Bernal, 2015, Acute liver failure: a curable disease by 2024?, J Hepatol, 62, S112, 10.1016/j.jhep.2014.12.016 · DOI · Paper page
  5. Kamimura, 2023, Analysis of drug-induced liver-related adverse event trend reporting between 1997 and 2019, Hepatol Res, 53, 556, 10.1111/hepr.13883 · DOI · Paper page
  6. Lee, 2017, Public health: acetaminophen (APAP) hepatotoxicity—isn’t it time for APAP to go away?, J Hepatol, 67, 1324, 10.1016/j.jhep.2017.07.005 · DOI · Paper page
  7. Reuben, 2016, Outcomes in adults with acute liver failure (ALF) from 1998-2013: An observational cohort study, Ann Intern Med, 164, 724, 10.7326/M15-2211 · DOI · Paper page
  8. Wendon, 2017, EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure, J Hepatol, 66, 1047, 10.1016/j.jhep.2016.12.003 · DOI · Paper page
  9. O'Grady, 1993, Acute liver failure: redefining the syndromes, Lancet, 342, 273, 10.1016/0140-6736(93)91736-6 · DOI · Paper page
  10. Reddy, 2016, Determinants of outcome among patients with acute liver failure listed for liver transplantation in the United States, Liver Transpl, 22, 505, 10.1002/lt.24347 · DOI · Paper page
  11. Murphy, 2016, Progress toward eliminating hepatitis A disease in the United States, MMWR Suppl, 65, 29, 10.15585/mmwr.su6501a6 · DOI · Paper page
  12. Somasekar, 2017, Viral surveillance in serum samples from patients with acute liver failure by metagenomic next-generation sequencing, Clin Infect Dis, 65, 1477, 10.1093/cid/cix596 · DOI · Paper page
  13. Ganger, 2018, Acute liver failure of indeterminate etiology: A comprehensive systematic approach by an expert committee to establish causality, Am J Gastroenterol, 113, 1319, 10.1038/s41395-018-0160-2 · DOI · Paper page
  14. Stravitz, 2011, Autoimmune acute liver failure: proposed clinical and histological criteria, Hepatology, 53, 517, 10.1002/hep.24080 · DOI · Paper page
  15. Enke, 2023, Autoimmune hepatitis presenting as acute liver failure. A 20-year retrospective review of North America, Liver Transpl, 29, 570, 10.1097/LVT.0000000000000105 · DOI
  16. Rockey, 2010, Causality assessment in drug-induced liver injury using a structured expert opinion process: Comparison to the Roussel-Uclaf causality assessment method, Hepatology, 51, 2117, 10.1002/hep.23577 · DOI · Paper page
  17. Rao, 2022, Secular trends in severe idiosyncratic drug-induced liver injury in North America: An update from the Acute Liver Failure Study Group Registry, Am J Gastroenterol, 117, 617, 10.14309/ajg.0000000000001655 · DOI · Paper page
  18. Squires, 2006, Acute liver failure in children: The first 348 patients in the pediatric acute liver failure study group, J Pediatr, 148, 652, 10.1016/j.jpeds.2005.12.051 · DOI · Paper page
  19. Zellos, 2022, Proceedings of ESPGHAN Monothematic Conference 2020: Acute liver failure in children: Diagnosis and initial management, J Pediatr Gastroenterol Nutr, 74, e45
  20. Squires, 2022, North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition Position Paper on the Diagnosis and Management of Pediatric Acute Liver Failure, J Pediatr Gastroenterol Nutr, 74, 138, 10.1097/MPG.0000000000003268 · DOI
  21. Di Giorgio, 2021, Diagnostic approach to acute liver failure in children: A position paper by the SIGENP liver disease working group, Dig Liv Dis, 53, 545, 10.1016/j.dld.2021.03.004 · DOI
  22. Narkewicz, 2018, A learning collaborative approach increases specificity of diagnosis of acute liver failure in pediatric patients, Clin Gastroenterol Hepatol, 16, 1801, 10.1016/j.cgh.2018.04.050 · DOI
  23. Li, 2016, Clinical course among cases of acute liver failure of indeterminate diagnosis, J Pediatr, 171, 163, 10.1016/j.jpeds.2015.12.065 · DOI
  24. Chapin, 2018, Indeterminate pediatric acute liver failure is uniquely characterized by a CD103(+) CD8(+) T-cell infiltrate, Hepatology, 68, 1087, 10.1002/hep.29901 · DOI
  25. Kulkarni, 2022, An update on pediatric acute liver failure: emerging understanding of the impact of immune dysregulation and novel opportunities for intervention, Clin Liver Dis, 26, 461, 10.1016/j.cld.2022.03.007 · doi:10.1016/j.cld.2022.03.007
  26. Lee, 2009, Intravenous N-acetylcysteine improves transplant-free survival in early stage non-acetaminophen acute liver failure, Gastroenterology, 137, 856, 10.1053/j.gastro.2009.06.006 · DOI · Paper page
  27. Sanabria-Cabrera, 2022, N-Acetylcysteine for the management of non-acetaminophen drug-induced liver injury in adults: A systematic review, Front Pharmacol, 13, 876868, 10.3389/fphar.2022.876868 · DOI · Paper page
  28. Squires, 2013, Intravenous N-acetylcysteine in pediatric patients with nonacetaminophen acute liver failure: A placebo-controlled clinical trial, Hepatology, 57, 1542, 10.1002/hep.26001 · DOI · Paper page
  29. Kelgeri, 2022, Clinical spectrum of children with acute hepatitis of unknown cause, N Engl J Med, 387, 611, 10.1056/NEJMoa2206704 · doi:10.1056/nejmoa2206704
  30. Pan, 2022, CAQ Corner: Acute liver failure management and liver transplantation, Liver Transpl, 28, 1664, 10.1002/lt.26503 · DOI · Paper page
  31. Squires, 2018, Liver transplant listing in pediatric acute liver failure: practices and participant characteristics, Hepatology, 68, 2338, 10.1002/hep.30116 · DOI
  32. Lefkowitch, 2016, The pathology of acute liver failure, Adv Anat Pathol, 23, 144, 10.1097/PAP.0000000000000112 · DOI
  33. Lisman, 2018, Platelets as modulators of liver diseases, Semin Thromb Hemost, 44, 114, 10.1055/s-0037-1604091 · DOI · Paper page
  34. Kleiner, 1997, Histopathologic changes associated with fialuridine hepatotoxicity, Mod Pathol, 10, 192
  35. Portmann, 1975, Histopathological changes in the liver following paracetamol overdose: correlation with clinical and biochemical parameters, J Pathol, 117, 169, 10.1002/path.1711170307 · DOI · Paper page
  36. Kleiner, 2009, The pathology of drug-induced liver injury, Semin Liver Dis, 29, 364, 10.1055/s-0029-1240005 · DOI · Paper page
  37. Shojaie, 2020, Cell death in liver diseases: a review, Int J Mol Sci, 21, 9682, 10.3390/ijms21249682 · DOI · Paper page
  38. Dara, 2015, Receptor interacting protein kinase 1 mediates murine acetaminophen toxicity independent of the necrosome and not through necroptosis, Hepatology, 62, 1847, 10.1002/hep.27939 · DOI · Paper page
  39. Rutherford, 2012, Development of an accurate index for predicting outcomes of patients with acute liver failure, Gastroenterology, 143, 1237, 10.1053/j.gastro.2012.07.113 · DOI · Paper page
  40. Singanayagam, 2021, Macrophages in chronic liver failure: dDiversity, plasticity and therapeutic targeting, Front Immunol, 12, 661182, 10.3389/fimmu.2021.661182 · DOI
  41. Triantafyllou, 2018, The role of monocytes and macrophages in acute and acute-on-chronic liver failure, Front Immunol, 9, 2948, 10.3389/fimmu.2018.02948 · DOI · Paper page
  42. Antoniades, 2014, Secretory leukocyte protease inhibitor: a pivotal mediator of anti-inflammatory responses in acetaminophen-induced acute liver failure, Hepatology, 59, 1564, 10.1002/hep.26933 · DOI · Paper page
  43. Triantafyllou, 2021, PD-1 blockade improves Kupffer cell bacterial clearance in acute liver injury, J Clin Invest, 131, e140196, 10.1172/JCI140196 · DOI · Paper page
  44. Slaba, 2015, Imaging the dynamic platelet-neutrophil response in sterile liver injury and repair in mice, Hepatology, 62, 1593, 10.1002/hep.28003 · DOI · Paper page
  45. Chauhan, 2020, The platelet receptor CLEC-2 blocks neutrophil mediated hepatic recovery in acetaminophen induced acute liver failure, Nat Commun, 11, 1939, 10.1038/s41467-020-15584-3 · DOI · Paper page
  46. Mehendale, 2005, Tissue repair: an important determinant of final outcome of toxicant-induced injury, Toxicol Pathol, 33, 41, 10.1080/01926230590881808 · DOI · Paper page
  47. Ramachandran, 2019, Acetaminophen hepatotoxicity, Semin Liver Dis, 39, 221, 10.1055/s-0039-1679919 · DOI · Paper page
  48. Little, 2019, Herpes simplex virus-associated acute liver failure often goes unrecognized, Hepatology, 69, 917, 10.1002/hep.30236 · DOI
  49. Ajmera, 2011, What factors determine the severity of hepatitis A related acute liver failure?, J Viral Hep, 18, e174, 10.1111/j.1365-2893.2010.01410.x · DOI
  50. Jouanguy, 2020, Human genetic basis of fulminant viral hepatitis, Human Genetics, 139, 877, 10.1007/s00439-020-02166-y · DOI
  51. Belkaya, 2019, Inherited IL-18BP deficiency in human fulminant viral hepatitis, J Exp Med, 216, 1777, 10.1084/jem.20190669 · DOI
  52. Hinson, 1995, Mechanisms of acetaminophen toxicity: immunochemical detection of drug-protein adducts, Drug Metabol Rev, 27, 73, 10.3109/03602539509029816 · DOI
  53. Khandelwal, 2011, Unrecognized acetaminophen toxicity as a cause of indeterminate acute liver failure, Hepatology, 53, 567, 10.1002/hep.24060 · DOI · Paper page
  54. Muldrew, 2002, Determination of acetaminophen-protein adducts in mouse liver and serum and human serum after hepatotoxic doses of acetaminophen using high-performance liquid chromatography with electrochemical detection, Drug Metab Dispos, 30, 446, 10.1124/dmd.30.4.446 · DOI · Paper page
  55. Roberts, 2017, An immunoassay to rapidly measure acetaminophen protein adducts accurately identifies patients with acute liver injury or failure, Clin Gastroenterol Hepatol, 15, 555, 10.1016/j.cgh.2016.09.007 · DOI · Paper page
  56. Rabinowich, 2016, Clinical management of acute liver failure: results of an international multi-center survey, World J Gastroenterol, 22, 7595, 10.3748/wjg.v22.i33.7595 · DOI · Paper page
  57. Bernal, 2013, Lessons from look-back in acute liver failure ? A single centre experience of 3300 patients, J Hepatol, 59, 74, 10.1016/j.jhep.2013.02.010 · DOI · Paper page
  58. MacDonald, 2021, Clinical and neurologic outcomes in acetaminophen induced acute liver failure: A 21-year multicenter cohort study, Clin Gastroenterol Hepatol, 19, 2615, 10.1016/j.cgh.2020.09.016 · DOI · Paper page
  59. Bernal, 2002, Blood lactate as an early predictor of outcome in paracetamol-induced acute liver failure: a cohort study, Lancet, 359, 558, 10.1016/S0140-6736(02)07743-7 · DOI · Paper page
  60. Bernal, 2016, Development and validation of a dynamic outcome prediction model for paracetamol-induced acute liver failure: a cohort study, Lancet Gastroenterol Hepatol, 1, 217, 10.1016/S2468-1253(16)30007-3 · DOI
  61. Bismuth, 1995, Orthotopic liver transplantation in fulminant and subfulminant hepatitis. The Paul Brousse experience, Ann Surg, 222, 109, 10.1097/00000658-199508000-00002 · DOI · Paper page
  62. McPhail, 2010, Meta-analysis of performance of Kings’s College Hospital Criteria in prediction of outcome in non-paracetamol-induced acute liver failure, J Hepatol, 53, 492, 10.1016/j.jhep.2010.03.023 · DOI
  63. Cholongitas, 2012, Comparison of the sequential organ failure assessment score with the King’s College Hospital criteria and the model for end-stage liver disease score for the prognosis of acetaminophen-induced acute liver failure, Liver Transpl, 18, 405, 10.1002/lt.23370 · DOI · Paper page
  64. Koch, 2016, Development of a model to predict transplant-free survival of patients with acute liver failure, Clin Gastroenterol Hepatol, 14, 1199, 10.1016/j.cgh.2016.03.046 · DOI · Paper page
  65. Everson, 2012, Quantitative liver function tests improve the prediction of clinical outcomes in chronic hepatitis C: Results from the Hepatitis C Antiviral Long-term Treatment Against Cirrhosis Trial, Hepatology, 55, 1019, 10.1002/hep.24752 · DOI
  66. Fontana, 2021, Prognostic value of the 13C-methacetin breath test in adults with acute liver failure and non-acetaminophen acute liver injury, Hepatology, 74, 961, 10.1002/hep.31783 · DOI
  67. Rakela, 2023, Acute liver failure: biomarkers evaluated by the acute liver failure study group, Clin Translat Gastroenterol, 14, e00565, 10.14309/ctg.0000000000000565 · DOI
  68. Schiodt, 2006, Alpha-fetoprotein and prognosis in acute liver failure, Liver Transpl, 12, 1776, 10.1002/lt.20886 · DOI · Paper page
  69. Rutherford, 2007, Serum apoptosis markers in acute liver failure: A pilot study, Clin Gastroenterol Hepatol, 5, 1477, 10.1016/j.cgh.2007.08.007 · DOI
  70. Schiodt, 2007, Predictive value of actin-free Gc-globulin in acute liver failure, Liver Transpl, 13, 1324, 10.1002/lt.21236 · DOI
  71. Woolbright, 2014, Glycodeoxycholic acid levels as prognostic biomarker in acetaminophen-induced acute liver failure patients, Toxicol Sci, 142, 436, 10.1093/toxsci/kfu195 · DOI · Paper page
  72. Basta, 2015, Circulating levels of soluble receptor for advanced glycation end products and ligands of the receptor for advanced glycation end products in patients with acute liver failure, Liver Transpl, 21, 847, 10.1002/lt.24129 · DOI
  73. Srungaram, 2015, Plasma osteopontin in acute liver failure, Cytokine, 73, 270, 10.1016/j.cyto.2015.02.021 · DOI · Paper page
  74. Laursen, 2015, Circulating mannan-binding lectin, M-, L-, H-ficolin and collectin-liver-1 levels in patients with acute liver failure, Liver Int, 35, 756, 10.1111/liv.12682 · DOI
  75. Rosen, 2016, Association between plasma level of galectin-9 and survival of patients with drug-induced acute liver failure, Clin Gastroenterol Hepatol, 14, 606, 10.1016/j.cgh.2015.09.040 · DOI
  76. Karvellas, 2017, Elevated FABP1 serum levels are associated with poorer survival in acetaminophen-induced acute liver failure, Hepatology, 69, 938, 10.1002/hep.28945 · DOI · Paper page
  77. Karvellas, 2021, Elevated serum liver-type fatty acid binding protein levels in non-acetaminophen acute liver failure patients with organ dysfunction, Dig Dis Sci, 66, 273, 10.1007/s10620-020-06166-w · DOI
  78. Slowik, 2019, Leukocyte cell derived chemotaxin-2 (Lect2) as a predictor of survival in adult acute liver failure, Transl Gastroenterol Hepatol, 4, 17, 10.21037/tgh.2019.03.03 · DOI
  79. Tavabie, 2021, A novel microRNA-based prognostic model outperforms standard prognostic models in patients with acetaminophen-induced acute liver failure, J Hepatol, 75, 424, 10.1016/j.jhep.2021.03.013 · DOI
  80. Patidar, 2021, Admission Factor V predicts transplant-free survival in acute liver failure, Dig Dis Sci, 66, 619, 10.1007/s10620-020-06197-3 · DOI
  81. Stravitz, 2016, Thrombocytopenia is associated with multi-organ system failure in patients with acute liver failure, Clin Gastroenterol Hepatol, 14, 613, 10.1016/j.cgh.2015.09.029 · DOI · Paper page
  82. Glavind, 2020, The macrophage activation marker soluble CD163 is elevated and associated with liver disease phenotype in patients with Wilson's disease, Orphanet J Rare Dis, 15, 173, 10.1186/s13023-020-01452-2 · DOI
  83. Strnad, 2010, Keratin variants predispose to acute liver failure and adverse outcome: race and ethnic associations, Gastroenterology, 139, 828, 10.1053/j.gastro.2010.06.007 · DOI · Paper page
  84. Court, 2013, The UDP-glucuronosyltransferase (UGT) 1A polymorphism c.2042C > G (rs8330) is associated with increased human liver acetaminophen glucuronidation, increased UGT1A exon 5a/5b splice variant mRNA ratio, and decreased risk of unintentional acetaminophen-induced acute liver failure, J Pharmacol Exp Ther, 345, 297, 10.1124/jpet.112.202010 · DOI
  85. Randesi, 2017, Association of variants of arginine vasopressin and arginine vasopressin receptor 1A with severe acetaminophen liver injury, Cell Mol Gastroenterol Hepatol, 3, 500, 10.1016/j.jcmgh.2017.01.008 · DOI
  86. Ajmera, 2019, Host genetic variant in CXCL16 may be associated with hepatitis B virus-related acute liver failure, Cell Mol Gastroenterol Hepatol, 7, 477, 10.1016/j.jcmgh.2018.09.018 · DOI
  87. Dao, 2012, Use of nucleoside (tide) analogues in patients with hepatitis B-related acute liver failure, Dig Dis Sci, 57, 1349, 10.1007/s10620-011-2013-3 · DOI · Paper page
  88. Butterworth, 2015, Pathogenesis of hepatic encephalopathy and brain edema in acute liver failure, J Clin Exp Hepatol, 5, S96, 10.1016/j.jceh.2014.02.004 · DOI
  89. Bernal, 2007, Arterial ammonia and clinical risk factors for encephalopathy and intracranial hypertension in acute liver failure, Hepatology, 46, 1844, 10.1002/hep.21838 · DOI · Paper page
  90. Stravitz, 2018, Safety, tolerability and pharmacokinetics of L-ornithine phenylacetate in patients with acute liver injury/failure and hyperammonemia, Hepatology, 67, 1003, 10.1002/hep.29621 · DOI
  91. Vaquero, 2005, Complications and use of intracranial pressure monitoring in patients with acute liver failure and severe encephalopathy, Liver Transpl, 11, 1581, 10.1002/lt.20625 · DOI · Paper page
  92. Karvellas, 2014, Outcomes and complications of intracranial pressure monitoring in acute liver failure: a retrospective cohort study, Crit Care Med, 42, 1157, 10.1097/CCM.0000000000000144 · DOI · Paper page
  93. Stravitz, 2018, Bleeding complications in acute liver failure, Hepatology, 67, 1931, 10.1002/hep.29694 · DOI · Paper page
  94. Rajajee, 2011, Optic nerve ultrasound for the detection of raised intracranial pressure, Neurocrit Care, 15, 506, 10.1007/s12028-011-9606-8 · doi:10.1007/s12028-011-9606-8
  95. Rajajee, 2018, Noninvasive intracranial pressure assessment in acute liver failure, Neurocrit Care, 29, 280, 10.1007/s12028-018-0540-x · DOI
  96. Kawakami, 2010, Cerebral pulsatility index by transcranial Doppler sonography predicts the prognosis of patients with fulminant hepatic failure, Clin Imaging, 34, 327, 10.1016/j.clinimag.2009.09.006 · doi:10.1016/j.clinimag.2009.09.006
  97. Murphy, 2004, The effect of hypertonic sodium chloride on intracranial pressure in patients with acute liver failure, Hepatology, 39, 464, 10.1002/hep.20056 · DOI · Paper page
  98. Cardoso, 2018, Continuous renal replacement therapy is associated with reduced serum ammonia levels and mortality in acute liver failure, Hepatology, 67, 711, 10.1002/hep.29488 · DOI · Paper page
  99. Bernal, 2016, A multicentre randomized controlled trial of moderate hypothermia to prevent intracranial hypertension in acute liver failure, J Hepatol, 65, 273, 10.1016/j.jhep.2016.03.003 · DOI
  100. Nanchal, 2020, Guidelines for the management of adult acute and acute-on-chronic liver failure in the ICU: Cardiovascular, endocrine, hematologic, pulmonary, and renal considerations, Crit Care Med, 48, e173, 10.1097/CCM.0000000000004192 · DOI · Paper page
  101. Canalese, 1982, Controlled trial of dexamethasone and mannitol for the cerebral oedema of fulminant hepatic failure, Gut, 23, 625, 10.1136/gut.23.7.625 · DOI · Paper page
  102. Jalan, 2004, Moderate hypothermia in patients with acute liver failure and uncontrolled intracranial hypertension, Gastroenterology, 127, 1338, 10.1053/j.gastro.2004.08.005 · DOI · Paper page
  103. Forbes, 1989, Thiopental infusion in the treatment of intracranial hypertension complicating fulminant hepatic failure, Hepatology, 10, 306, 10.1002/hep.1840100309 · DOI · Paper page
  104. Muñoz, 1991, Elevated intracranial pressure and computed tomography of the brain in fulminant hepatocellular failure, Hepatology, 13, 209, 10.1002/hep.1840130202 · DOI
  105. Kalal, 2022, Mannitol is comparable to hypertonic saline for raised intracranial pressure in acute liver failure (MAHAL Study): a randomized controlled trial, Dig Dis, 40, 607, 10.1159/000520229 · DOI
  106. Vaquero, 2007, Mild hypothermia attenuates liver injury and improves survival in mice with acetaminophen toxicity, Gastroenterology, 132, 372, 10.1053/j.gastro.2006.11.025 · DOI
  107. Karvellas, 2015, Therapeutic hypothermia in acute liver failure: A multicenter retrospective cohort analysis, Liver Transpl, 21, 4, 10.1002/lt.24021 · DOI
  108. Fernando, 2021, Targeted temperature management following out-of-hospital cardiac arrest: A systematic review and network meta-analysis of temperature targets, Intensive Care Med, 47, 1078, 10.1007/s00134-021-06505-z · DOI
  109. Dong, 2020, Significant lung injury and its prognostic significance in acute liver failure: A cohort analysis, Liver Int, 40, 654, 10.1111/liv.14268 · DOI
  110. Antoniades, 2008, The importance of immune dysfunction in determining outcome in acute liver failure, J Hepatol, 49, 845, 10.1016/j.jhep.2008.08.009 · DOI · Paper page
  111. Taylor, 2013, Circulating neutrophil dysfunction in acute liver failure, Hepatology, 57, 1142, 10.1002/hep.26102 · DOI · Paper page
  112. Rolando, 1996, Prospective study comparing the efficacy of prophylactic parenteral antimicrobials, with or without enteral decontamination, in patients with acute liver failure, Liver Transpl Surg, 2, 8, 10.1002/lt.500020103 · DOI
  113. Karvellas, 2014, Effects of antimicrobial prophylaxis and blood stream infections in patients with acute liver failure: A retrospective cohort study, Clin Gastroenterol Hepatol, 12, 1942, 10.1016/j.cgh.2014.03.011 · DOI · Paper page
  114. Vaquero, 2003, Infection and the progression of hepatic encephalopathy in acute liver failure, Gastroenterology, 125, 755, 10.1016/S0016-5085(03)01051-5 · DOI · Paper page
  115. Rolando, 1991, Fungal infection: A common, unrecognised complication of acute liver failure, J Hepatol, 12, 1, 10.1016/0168-8278(91)90900-V · DOI · Paper page
  116. Rolando, 2000, The systemic inflammatory response syndrome in acute liver failure, Hepatology, 32, 734, 10.1053/jhep.2000.17687 · DOI · Paper page
  117. Harry, 2002, The clinical importance of adrenal insufficiency in acute hepatic dysfunction, Hepatology, 36, 395, 10.1053/jhep.2002.34514 · DOI · Paper page
  118. Larsen, 2016, High-volume plasma exchange in patients with acute liver failure: An open randomised controlled trial, J Hepatol, 64, 69, 10.1016/j.jhep.2015.08.018 · DOI · Paper page
  119. Driever, 2021, VWF/ADAMTS13 imbalance, but not global coagulation or fibrinolysis, is associated with outcome and bleeding in acute liver failure, Hepatology, 73, 1882, 10.1002/hep.31507 · DOI
  120. Stravitz, 2013, Role of procoagulant microparticles in mediating complications and outcome of acute liver injury/acute liver failure, Hepatology, 58, 304, 10.1002/hep.26307 · DOI · Paper page
  121. Stravitz, 2012, Minimal effects of acute liver injury/acute liver failure on hemostasis as assessed by thromboelastography, J Hepatol, 56, 129, 10.1016/j.jhep.2011.04.020 · DOI · Paper page
  122. Lisman, 2012, Intact thrombin generation and decreased fibrinolytic capacity in patients with acute liver injury or acute liver failure, J Thromb Haemost, 10, 1312, 10.1111/j.1538-7836.2012.04770.x · DOI
  123. Lisman, 2015, Rebalanced hemostasis in patients with acute liver failure, Semin Thromb Hemost, 41, 468, 10.1055/s-0035-1550430 · DOI · Paper page
  124. Pereira, 2005, Pharmacokinetics and efficacy of oral versus intravenous mixed-micellar phylloquinone (vitamin K1) in severe acute liver disease, J Hepatol, 42, 365, 10.1016/j.jhep.2004.11.030 · doi:10.1016/j.jhep.2004.11.030
  125. Leithead, 2009, The systemic inflammatory response syndrome is predictive of renal dysfunction in patients with non-paracetamol-induced acute liver failure, Gut, 58, 443, 10.1136/gut.2008.154120 · DOI · Paper page
  126. Warrillow, 2020, Correction and control of hyperammonemia in acute liver failure: The impact of continuous renal replacement timing, intensity, and duration, Crit Care Med, 48, 218, 10.1097/CCM.0000000000004153 · DOI
  127. Fisher, 2022, Ammonia clearance with different continuous renal replacement therapy techniques in patients with liver failure, Blood Purif, 51, 840, 10.1159/000521312 · DOI
  128. Slack, 2014, Ammonia clearance with haemofiltration in adults with liver disease, Liver Int, 34, 42, 10.1111/liv.12221 · DOI · Paper page
  129. Hamdi, 2018, High sodium continuous veno-venous hemodialysis with regional citrate anticoagulation and online dialysate generation in patients with acute liver failure and cerebral edema, Hemodial Int, 22, 184, 10.1111/hdi.12572 · DOI
  130. Saliba, 2022, Artificial liver support in patients with liver failure: a modified DELPHI consensus of international experts, Int Care Med, 48, 1352
  131. Tandon, 2021, Artificial liver support systems, J Gastro & Hepatol, 36, 1164, 10.1111/jgh.15255 · DOI
  132. MacDonald, 2022, Use of the molecular adsorbent recirculating system in acute liver failure: results of a multicenter propensity score-matched study, Crit Care Med, 50, 286, 10.1097/CCM.0000000000005194 · DOI
  133. Saliba, 2013, Albumin dialysis with a noncell artificial liver support device in patients with acute liver failure: a randomized, controlled trial, Ann Intern Med, 159, 522, 10.7326/0003-4819-159-8-201310150-00005 · DOI · Paper page
  134. Glorioso, 2015, Pivotal preclinical trial of the spheroid reservoir bioartificial liver, J Hepatology, 63, 388, 10.1016/j.jhep.2015.03.021 · DOI · Paper page
  135. Huang, 2014, Direct reprogramming of human fibroblasts to functional and expandable hepatocytes, Cell Stem Cell, 14, 370, 10.1016/j.stem.2014.01.003 · DOI · Paper page
  136. Zhou, 2019, Stem cell-related studies and stem cell-based therapies in liver diseases, Cell Transplant, 28, 1116, 10.1177/0963689719859262 · DOI
  137. Yao, 2022, Induced pluripotent stem cells for the treatment of liver diseases: Novel concepts, Cells, Tissues and Organs, 211, 368
  138. Wu, 2017, Interspecies chimerism with mammalian pluripotent stem cells, Cell, 168, 473, 10.1016/j.cell.2016.12.036 · DOI · Paper page
  139. Larson, 2021, Fumarylacetoacetate hydrolase gene as a knockout target for hepatic chimerism and donor liver production, Stem Cell Reports, 16, 2577, 10.1016/j.stemcr.2021.09.018 · DOI
  140. Karvellas, 2010, Medical and psychiatric outcomes for patients transplanted for acetaminophen-induced acute liver failure: A case-control study, Liver Int, 30, 826, 10.1111/j.1478-3231.2010.02243.x · DOI
  141. Pezzia, 2017, Psychosocial and behavioral factors in acetaminophen-related acute liver failure and liver injury, J Psychosom Res, 101, 51, 10.1016/j.jpsychores.2017.08.006 · DOI
  142. Germani, 2012, Liver transplantation for acute liver failure in Europe: Outcomes over 20 years from the ELTR database, J Hepatol, 57, 288, 10.1016/j.jhep.2012.03.017 · DOI · Paper page
  143. Karvellas, 2022, Outcomes of acute liver failure patients listed for liver transplantation: A multicenter prospective cohort analysis, Liver Transpl

Cited by

See all 132

Metadata

Authors
Stravitz, R. T., Fontana, R. J., Karvellas, C., Durkalski, V., McGuire, B., Rule, J. A., Tujios, S., Lee, W. M., & for the Acute Liver Failure Study Group
Venue
Hepatology
Published
2023-05-16
Volume
78
Issue
4
Pages
1266-1289
ISSN
0270-9139 (ISSN-L)
OpenAlex
W4376616796
Cited by
132
References
21
FWCI
18.69
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Future directions in acute liver failure. https://app.cochat.ai/papers/10.1097/hep.0000000000000458
The paper
Stravitz, R. T., Fontana, R. J., Karvellas, C., Durkalski, V., McGuire, B., Rule, J. A., Tujios, S., Lee, W. M., & for the Acute Liver Failure Study Group. (2023). Future directions in acute liver failure. Hepatology. https://doi.org/10.1097/hep.0000000000000458

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.